Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.00%184.66M | -0.18%712.2M | -3.12%176.17M | -5.46%172.87M | 4.57%183.87M | 3.65%179.29M | -7.91%713.51M | -1.88%181.84M | 3.02%182.85M | -11.22%175.85M |
| Cost of revenue | -0.14%629.62M | -5.90%630.51M | ||||||||
| Gross profit | -0.52%82.57M | -20.78%83M | ||||||||
| Operating expense | 20.17%43.87M | -12.82%36.51M | ||||||||
| Selling and administrative expenses | ---- | 20.17%43.87M | ---- | ---- | ---- | ---- | -12.82%36.51M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 10.64%21.89M | ---- | ---- | ---- | ---- | -23.14%19.79M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 31.45%21.98M | ---- | ---- | ---- | ---- | 3.64%16.72M | ---- | ---- | ---- |
| Operating profit | 132.81%13.2M | -16.76%38.7M | -2.73%10.41M | -25.12%10.69M | 19.03%13.52M | -51.13%5.67M | -26.08%46.49M | -26.15%10.71M | 0.84%14.27M | -32.42%11.35M |
| Net non-operating interest income (expenses) | -11.95%-3.84M | 35.54%-3.43M | ||||||||
| Non-operating interest expense | -18.47%812K | 11.95%3.84M | 6.51%965K | 20.59%937K | 30.11%942K | -2.64%996K | -35.54%3.43M | -33.43%906K | -41.23%777K | -47.73%724K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | |||||||||
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 10.01%1.58M | -16.25%1.44M | ||||||||
| Income before tax | 165.05%12.39M | -18.11%36.44M | -3.58%9.45M | -27.75%9.75M | 18.28%12.57M | -55.82%4.67M | 21.63%44.5M | 224.70%9.8M | 5.18%13.49M | -31.04%10.63M |
| Income tax | 123.56%3.03M | -5.38%9.94M | 42.23%2.97M | -24.98%2.48M | 19.99%3.15M | -45.82%1.35M | 24.15%10.51M | 322.27%2.09M | 30.00%3.3M | 40.46%2.62M |
| Net income | 181.98%9.36M | -22.04%26.5M | -15.97%6.48M | -28.65%7.27M | 17.72%9.43M | -58.91%3.32M | 20.87%33.99M | 192.35%7.71M | -0.95%10.19M | -40.89%8.01M |
| Net income continuous operations | 181.98%9.36M | -22.04%26.5M | -15.97%6.48M | -28.65%7.27M | 17.72%9.43M | -58.91%3.32M | 20.87%33.99M | 192.35%7.71M | -0.95%10.19M | -40.89%8.01M |
| Noncontrolling interests | -79.20%88K | -126.21%-378K | -201.77%-922K | -75.14%43K | 966.67%78K | 13.71%423K | 118.45%1.44M | 110.66%906K | 13.82%173K | -105.23%-9K |
| Net income attributable to the company | 220.13%9.27M | -17.43%26.88M | 8.76%7.4M | -27.85%7.23M | 16.61%9.35M | -62.42%2.9M | -9.43%32.55M | 4,468.46%6.81M | -1.17%10.02M | -40.06%8.02M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 220.13%9.27M | -17.43%26.88M | 8.76%7.4M | -27.85%7.23M | 16.61%9.35M | -62.42%2.9M | -9.43%32.55M | 4,468.46%6.81M | -1.17%10.02M | -40.06%8.02M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 218.07%0.0264 | -17.35%0.0767 | 9.28%0.0212 | -27.97%0.0206 | 16.67%0.0266 | -62.27%0.0083 | -9.46%0.0928 | 4,750.00%0.0194 | -1.04%0.0286 | -40.31%0.0228 |
| Diluted earnings per share | 218.07%0.0264 | -17.35%0.0767 | 9.28%0.0212 | -27.97%0.0206 | 16.67%0.0266 | -62.27%0.0083 | -9.46%0.0928 | 4,750.00%0.0194 | -1.04%0.0286 | -40.31%0.0228 |
| Dividend per share | 0 | 50.00%0.075 | 0.00%0.025 | 0 | 100.00%0.05 | 0 | 0.00%0.05 | 0.00%0.025 | 0 | 0.00%0.025 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.